Colgate-Palmolive Company $CL Shares Acquired by Grantham Mayo Van Otterloo & Co. LLC

Grantham Mayo Van Otterloo & Co. LLC boosted its position in Colgate-Palmolive Company (NYSE:CL) by 217.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 40,605 shares of the company’s stock after buying an additional 27,796 shares during the quarter. Grantham Mayo Van Otterloo & Co. LLC’s holdings in Colgate-Palmolive were worth $3,246,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Copia Wealth Management acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $29,000. Vermillion & White Wealth Management Group LLC boosted its holdings in Colgate-Palmolive by 86.1% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after purchasing an additional 155 shares during the period. Cloud Capital Management LLC bought a new stake in Colgate-Palmolive during the third quarter valued at $30,000. MTM Investment Management LLC bought a new stake in Colgate-Palmolive during the second quarter valued at $39,000. Finally, Louisbourg Investments Inc. raised its holdings in shares of Colgate-Palmolive by 94.7% during the third quarter. Louisbourg Investments Inc. now owns 514 shares of the company’s stock worth $41,000 after purchasing an additional 250 shares during the period. Institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on the stock. Bank of America lifted their price target on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a report on Monday, February 2nd. Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price on the stock in a report on Tuesday, December 9th. TD Cowen restated a “buy” rating on shares of Colgate-Palmolive in a research note on Monday, February 2nd. UBS Group upped their target price on Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a report on Wednesday, January 14th. Finally, Morgan Stanley increased their price target on Colgate-Palmolive from $87.00 to $100.00 and gave the stock an “overweight” rating in a research report on Monday, February 2nd. Eleven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $94.75.

Colgate-Palmolive Trading Down 0.6%

Shares of NYSE:CL opened at $92.45 on Wednesday. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. The company’s 50-day moving average price is $89.50 and its 200 day moving average price is $83.13. The company has a market cap of $74.52 billion, a PE ratio of 35.29, a P/E/G ratio of 4.17 and a beta of 0.28. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. The firm had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. Colgate-Palmolive’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.91 EPS. Sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Insiders Place Their Bets

In related news, CFO Stanley J. Sutula III sold 97,843 shares of the firm’s stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the sale, the chief financial officer directly owned 55,310 shares in the company, valued at $5,214,073.70. This trade represents a 63.89% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Sally Massey sold 15,851 shares of Colgate-Palmolive stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the sale, the insider directly owned 13,751 shares in the company, valued at $1,306,757.53. The trade was a 53.55% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 184,683 shares of company stock valued at $17,486,693. 0.41% of the stock is owned by corporate insiders.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.